Clinical Trial Update: Exploratory Lapatinib (Positron Emission Tomography) PET Study in Subjects With Breast Cancer [Phase 1]

View source ↗

Summary

An exploratory Phase 1 PET imaging study of lapatinib in breast cancer patients; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Lapatinib (Lapatinib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Cancer | Phase 1 | Status: COMPLETED